CanniMed Therapeutics Inc (TSE:CMED) insider Allan Mclay Fowler sold 31,777 shares of the company’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of C$31.81, for a total value of C$1,010,826.37.
Shares of CanniMed Therapeutics Inc (TSE:CMED) opened at C$35.52 on Thursday. The stock has a market capitalization of $879.36 and a P/E ratio of -31.71. CanniMed Therapeutics Inc has a 12-month low of C$7.32 and a 12-month high of C$46.00.
CanniMed Therapeutics Company Profile
CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.
Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.